245 related articles for article (PubMed ID: 33558692)
1. Highly efficient neuronal gene knockout in vivo by CRISPR-Cas9 via neonatal intracerebroventricular injection of AAV in mice.
Hana S; Peterson M; McLaughlin H; Marshall E; Fabian AJ; McKissick O; Koszka K; Marsh G; Craft M; Xu S; Sorets A; Torregrosa T; Sun C; Henderson CE; Lo SC
Gene Ther; 2021 Nov; 28(10-11):646-658. PubMed ID: 33558692
[TBL] [Abstract][Full Text] [Related]
2. Use of CRISPR/Cas9-mediated disruption of CNS cell type genes to profile transduction of AAV by neonatal intracerebroventricular delivery in mice.
Torregrosa T; Lehman S; Hana S; Marsh G; Xu S; Koszka K; Mastrangelo N; McCampbell A; Henderson CE; Lo SC
Gene Ther; 2021 Aug; 28(7-8):456-468. PubMed ID: 33612827
[TBL] [Abstract][Full Text] [Related]
3. sgRNA Sequence Motifs Blocking Efficient CRISPR/Cas9-Mediated Gene Editing.
Graf R; Li X; Chu VT; Rajewsky K
Cell Rep; 2019 Jan; 26(5):1098-1103.e3. PubMed ID: 30699341
[TBL] [Abstract][Full Text] [Related]
4. Guidelines for optimized gene knockout using CRISPR/Cas9.
Campenhout CV; Cabochette P; Veillard AC; Laczik M; Zelisko-Schmidt A; Sabatel C; Dhainaut M; Vanhollebeke B; Gueydan C; Kruys V
Biotechniques; 2019 Jun; 66(6):295-302. PubMed ID: 31039627
[TBL] [Abstract][Full Text] [Related]
5. Optimized Cas9:sgRNA delivery efficiently generates biallelic MSTN knockout sheep without affecting meat quality.
Zhou S; Kalds P; Luo Q; Sun K; Zhao X; Gao Y; Cai B; Huang S; Kou Q; Petersen B; Chen Y; Ma B; Wang X
BMC Genomics; 2022 May; 23(1):348. PubMed ID: 35524183
[TBL] [Abstract][Full Text] [Related]
6. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9-mediated gene knockout is insensitive to target copy number but is dependent on guide RNA potency and Cas9/sgRNA threshold expression level.
Yuen G; Khan FJ; Gao S; Stommel JM; Batchelor E; Wu X; Luo J
Nucleic Acids Res; 2017 Nov; 45(20):12039-12053. PubMed ID: 29036671
[TBL] [Abstract][Full Text] [Related]
8. Efficient CRISPR/Cas9-mediated biallelic gene disruption and site-specific knockin after rapid selection of highly active sgRNAs in pigs.
Wang X; Zhou J; Cao C; Huang J; Hai T; Wang Y; Zheng Q; Zhang H; Qin G; Miao X; Wang H; Cao S; Zhou Q; Zhao J
Sci Rep; 2015 Aug; 5():13348. PubMed ID: 26293209
[TBL] [Abstract][Full Text] [Related]
9. CRISPys: Optimal sgRNA Design for Editing Multiple Members of a Gene Family Using the CRISPR System.
Hyams G; Abadi S; Lahav S; Avni A; Halperin E; Shani E; Mayrose I
J Mol Biol; 2018 Jul; 430(15):2184-2195. PubMed ID: 29625203
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9 with single guide RNA expression driven by small tRNA promoters showed reduced editing efficiency compared to a U6 promoter.
Wei Y; Qiu Y; Chen Y; Liu G; Zhang Y; Xu L; Ding Q
RNA; 2017 Jan; 23(1):1-5. PubMed ID: 27742910
[TBL] [Abstract][Full Text] [Related]
11. An Optimized CRISPR/Cas9 Adenovirus Vector (AdZ-CRISPR) for High-Throughput Cloning of sgRNA, Using Enhanced sgRNA and Cas9 Variants.
Statkute E; Wang ECY; Stanton RJ
Hum Gene Ther; 2022 Sep; 33(17-18):990-1001. PubMed ID: 35196879
[TBL] [Abstract][Full Text] [Related]
12. Efficient Cas9 multiplex editing using unspaced sgRNA arrays engineering in a Potato virus X vector.
Uranga M; Aragonés V; Selma S; Vázquez-Vilar M; Orzáez D; Daròs JA
Plant J; 2021 Apr; 106(2):555-565. PubMed ID: 33484202
[TBL] [Abstract][Full Text] [Related]
13. Targeted Transgenic Mice Using CRISPR /Cas9 Technology.
El Marjou F; Jouhanneau C; Krndija D
Methods Mol Biol; 2021; 2214():125-141. PubMed ID: 32944907
[TBL] [Abstract][Full Text] [Related]
14. Optimization Strategies for the CRISPR-Cas9 Genome-Editing System.
Vejnar CE; Moreno-Mateos MA; Cifuentes D; Bazzini AA; Giraldez AJ
Cold Spring Harb Protoc; 2016 Oct; 2016(10):. PubMed ID: 27698246
[TBL] [Abstract][Full Text] [Related]
15. Optimizing sgRNA length to improve target specificity and efficiency for the GGTA1 gene using the CRISPR/Cas9 gene editing system.
Matson AW; Hosny N; Swanson ZA; Hering BJ; Burlak C
PLoS One; 2019; 14(12):e0226107. PubMed ID: 31821359
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9-mediated 2-sgRNA cleavage facilitates pseudorabies virus editing.
Tang YD; Guo JC; Wang TY; Zhao K; Liu JT; Gao JC; Tian ZJ; An TQ; Cai XH
FASEB J; 2018 Aug; 32(8):4293-4301. PubMed ID: 29509513
[TBL] [Abstract][Full Text] [Related]
17. [Construction of a striatum-specific Slc20a2 gene knockout mice model by CRISPR/Cas9 AAV system].
Lin MT; Lai LL; Zhao M; Lin BW; Yao XP
Yi Chuan; 2020 Oct; 42(10):1017-1027. PubMed ID: 33229326
[TBL] [Abstract][Full Text] [Related]
18. Genome Editing with CRISPR-Cas9: Can It Get Any Better?
Haeussler M; Concordet JP
J Genet Genomics; 2016 May; 43(5):239-50. PubMed ID: 27210042
[TBL] [Abstract][Full Text] [Related]
19. In Vivo Ryr2 Editing Corrects Catecholaminergic Polymorphic Ventricular Tachycardia.
Pan X; Philippen L; Lahiri SK; Lee C; Park SH; Word TA; Li N; Jarrett KE; Gupta R; Reynolds JO; Lin J; Bao G; Lagor WR; Wehrens XHT
Circ Res; 2018 Sep; 123(8):953-963. PubMed ID: 30355031
[TBL] [Abstract][Full Text] [Related]
20. Versatile and precise gene-targeting strategies for functional studies in mammalian cell lines.
Wassef M; Luscan A; Battistella A; Le Corre S; Li H; Wallace MR; Vidaud M; Margueron R
Methods; 2017 May; 121-122():45-54. PubMed ID: 28499832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
